BROOKE PORTO: Open Payments
NPI 1861131021 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,858 in 204 payments from 14 companies in 2025. Trend: 2023 $1,748 · 2024 $3,084 · 2025 $2,858
Food & beverage: $2,665Education: $193
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 99 | $1,208 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 55 | $786 |
| ABBVIE INC. | 16 | $322 |
| PFIZER INC. | 18 | $198 |
| Madrigal Pharmaceuticals | 2 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| GENZYME CORPORATION | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TREMFYA, XIFAXAN, RELISTOR, VELSIPITY, RINVOQ, REZDIFFRA, CREON, DUPIXENT.
Industry payments across NY — which companies pay providers there.
